Please read the important disclaimer at the following link before proceeding further on this page. The administrator of this forum is not a doctor nor licensed or experienced in any aspect of the health care industry.
https://www.covid-19forum.org/index.php?topic=227.0[update 4/11/2023] It's important to bear in mind that monoclonal antibody treatment for COVID-19 is an experimental therapy.
https://duckduckgo.com/?q=monoclonal+antibodies+covid+experimental+carcenogenic&va=w&t=ha&ia=webAnd equally important to bear in mind that there have been safe, generic drug/nutraceutical treatment protocols that have been proven virtually 100% effective in EARLY treatment of even elderly and high-risk individuals ever since March of 2020. Compare those therapies.....
https://duckduckgo.com/?q=monoclonal+antibodies+covid+experimental+carcenogenic&va=w&t=ha&ia=web.....with studies of the very expensive, patented, monoclonal antibodies by name at this important site:
https://c19early.org/ [end edit]
On to old thread:Monoclonal antibodies belong more in the early treatment section because they are antiviral recommended within the first 7-10 days of the onset of symptoms.
But since they are administered by an intravenous infusion, this needs to be done in a clinic or in early hospital admission, so this post is included in this late treatment section because of hospitalization.
There are a number of studies that demonstrate the efficacy of this therapy that are covered in the monoclonal antibodies thread at this link to the early treatment section:
https://www.covid-19forum.org/index.php?topic=642.0
